Back to ROYCE & ASSOCIATES LP ROYCE & ASSOCIATES LP

BBOTBBOT
2 quarters

Position history for ROYCE & ASSOCIATES LPROYCE & ASSOCIATES LP's holdings in BRIDGEBIO ONCOLOGY THERAPEUT

Yes. Royce & Associates holds 384,941 shares of BBOT (Bridgebio Oncology Therapeut), worth $2.9M, as of its Q2 2026 13F filing. It reduced the position by 251,581 shares (-39.5%) from Q1 2026. Royce & Associates has held BBOT since Q1 2026, across 2 quarterly 13F filings.

Current Value

$2.9M

Current Shares

384,941

Total Value Change

-$2.8M

Total Shares Change

-251,581

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
384,941
-39.5%
$2.9M0.0%$7.62
0
2026-Q1
New
636,522
-
$5.7M0.1%$9.74
37

Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used